Intensity Therapeutics Inc (INTS)

Feb 21, 2025

Equillium (NASDAQ:EQ) Stock Quotes, Forecast and News Summary - Benzinga

Feb 21, 2025

Feb 03, 2025

Intensity Infrastucture Partners Launches Open Season for New Natural Gas Transmission Pipeline to Serve the Bakken Region - Yahoo Finance

Feb 03, 2025

Feb 03, 2025

Clinical Trials News Live Feed - StockTitan

Feb 03, 2025

Jan 28, 2025

Drug Monitoring Committee Authorizes Continuation of Intensity T - GuruFocus.com

Jan 28, 2025

Jan 28, 2025

Intensity Therapeutics' sarcoma trial proceeds after review By Investing.com - Investing.com Canada

Jan 28, 2025

Jan 28, 2025

Intensity Therapeutics' sarcoma trial proceeds after review - Investing.com India

Jan 28, 2025

Jan 28, 2025

Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review - Nasdaq

Jan 28, 2025

Jan 28, 2025

High Intensity Focused Ultrasound Market Forecast and Company Analysis 2025-2033 Featuring Koninklijke Philips, Johnson & Johnson, Hitachi, General Electrics, Medtronic, Stryker, EDAP TMS, Theraclion - Yahoo Finance

Jan 28, 2025

Jan 23, 2025

vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News Summary - Benzinga

Jan 23, 2025

Jan 21, 2025

Soft Tissue Sarcoma Market Poised for Significant Growth from - openPR

Jan 21, 2025

Jan 15, 2025

Soft Tissue Sarcoma Pipeline Review 2024: Clinical Trials - openPR

Jan 15, 2025

Jan 13, 2025

Alliance Global Partners Initiates Coverage of Intensity Therapeutics (INTS) with Buy Recommendation - MSN

Jan 13, 2025

Jan 10, 2025

Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6 - PR Newswire

Jan 10, 2025

Jan 10, 2025

Avoiding Isolation By Volunteering Offers Mental Health Benefits to Seniors - 69News WFMZ-TV

Jan 10, 2025

Jan 06, 2025

Retrospective Analysis of Dosimetric Comparison Between Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy in Patients With Esophageal Cancer - Cureus

Jan 06, 2025

Jan 01, 2025

Intensity Therapeutics stock hits 52-week low at $1.73 By Investing.com - Investing.com Australia

Jan 01, 2025

Dec 31, 2024

Intensity Therapeutics stock hits 52-week low at $1.73 - Investing.com

Dec 31, 2024

Dec 30, 2024

Internal Radiation Therapy - Market.us

Dec 30, 2024

Dec 27, 2024

Exicure joins hands with GPCR Therapeutics for growth in biotech (NASDAQ:XCUR) - Seeking Alpha

Dec 27, 2024

Dec 24, 2024

Myelodysplastic Syndrome (MDS) Drugs Market Trends and Sales Forecast to 2030: Total Revenues to Reach US$4.1 Billion Worldwide, with Immunomodulatory Drugs Dominating Shares - GlobeNewswire

Dec 24, 2024

Dec 20, 2024

Intensity Therapeutics Stock Hits 52-Week Low at $1.76 By Investing.com - Investing.com Australia

Dec 20, 2024

Dec 20, 2024

Intensity Therapeutics Stock Hits 52-Week Low at $1.76 - Investing.com

Dec 20, 2024

Dec 20, 2024

Top pharma biotech companies R&D intensity globally 2023 - Statista

Dec 20, 2024

Dec 13, 2024

Why Is Repare Therapeutics Stock Trading Lower On Friday? - Yahoo Finance

Dec 13, 2024

Dec 13, 2024

SPR® Therapeutics Recognized as the Fastest Growing Private Company in Northeast Ohio as Part of the Crain’s Fast 50 List - Yahoo Finance

Dec 13, 2024

Dec 13, 2024

Intensity Therapeutics reports positive results of INT230-6 in breast cancer - Yahoo Finance

Dec 13, 2024

Dec 13, 2024

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients - Yahoo Finance

Dec 13, 2024

Dec 13, 2024

Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - Insider Monkey

Dec 13, 2024

Dec 12, 2024

Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Brea - Yahoo Finance

Dec 12, 2024